Showing results (151-160 of 365) with videos related to
Sort By:
Pageof 37
Cancer Research and Treatment|January 10, 2022
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical ExperienceJi-Yeon Kim, Seok Jin Nam, Jeong Eon Lee, et al.Breast Cancer Research and Treatment|July 23, 2015
Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort studyDanbee Kang, Im-Ryung Kim, Young Hyuck Im, et al.JCO Precision Oncology|January 14, 2026
Oncologic Outcomes by Pathogenic BRCA Mutation Status in Young Luminal Breast Cancer: A Propensity-Matched CohortWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.Journal of Breast Cancer|April 3, 2015
Proportion and clinical outcomes of postoperative radiotherapy omission after breast-conserving surgery in women with breast cancerJeong Il Yu, Doo Ho Choi, Seung Jae Huh, et al.Frontiers in Oncology|March 22, 2021
The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort StudyKyoungmin Lee, Sung Hoon Sim, Eun Joo Kang, et al.Scientific Reports|April 1, 2022
Temporal patterns of chronic disease incidence after breast cancer: a nationwide population-based cohort studyDanbee Kang, Minwoong Kang, Yun Soo Hong, et al.Journal of Global Oncology|July 2, 2019
Clinical Features and Outcomes of Invasive Breast Cancer: Age-Specific Analysis of a Modern Hospital-Based RegistryJi-Yeon Kim, Danbee Kang, Seok Jin Nam, et al.Blood|April 13, 2006
FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphomaDong Hwan Kim, Hee Du Jung, Jong Gwang Kim, et al.Breast Cancer (Tokyo, Japan)|March 13, 2024
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profileDanbee Kang, Seri Park, Hyo Jung Kim, et al.Oncotarget|September 24, 2015
Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancerYeon Hee Park, Hyun-Tae Shin, Hae Hyun Jung, et al.Pageof 37